Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Portfolio News / By admin April 24, 2019 Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Read More »
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Portfolio News / By admin April 22, 2019 Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Read More »
Gritstone Oncology Announces Proposed Public Offering of Common Stock Portfolio News / By admin April 22, 2019 Gritstone Oncology Announces Proposed Public Offering of Common Stock Read More »
Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Portfolio News / By admin April 11, 2019 Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Read More »
NGM Bio Announces Pricing of Initial Public Offering Portfolio News / By admin April 3, 2019 NGM Bio Announces Pricing of Initial Public Offering Read More »
Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001 Portfolio News / By admin March 21, 2019 Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001 Read More »
NGM Bio Appoints Hsiao D. Lieu, M.D. as SVP, Chief Medical Officer and Alex DePaoli, M.D. to New Role of SVP, Chief Translational Officer Portfolio News / By admin March 20, 2019 NGM Bio Appoints Hsiao D. Lieu, M.D. as SVP, Chief Medical Officer and Alex DePaoli, M.D. to New Role of SVP, Chief Translational Officer Read More »
Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidate Portfolio News / By admin March 14, 2019 Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidate Read More »
Immune Design acquired by Merck for approx. $300M Portfolio News / By admin February 21, 2019 Immune Design acquired by Merck for approx. $300M Read More »
Kallyope Inc. Appoints Brett Lauring as Chief Medical Officer Portfolio News / By admin February 5, 2019 Kallyope Inc. Appoints Brett Lauring as Chief Medical Officer Read More »
